genOway Shanghai at the Chinese Biopharmaceutical Association meeting 2024
Conference
The genOway Shanghai team participated in the CBA annual meeting, which hosted over 10,000 attendees, introducing genOway’s preclinical models to the Chinese scientific community.
During the conference, Marième NDJIM, PhD, Senior Business Developer at genOway, delivered an insightful presentation on how the predictability of our models accelerates the development of safer and more effective next-generation drugs.
We are very happy about the collaboration between our teams in France and China and the enthusiasm of all the clients we met.
Other news & events
Ultimate predictive models
Physiological relevance
Comprehensive and reliable validation data
Over 600 scientific articles based on our models
Scientific excellence
In-depth expertise in preclinical science, physiology, and model development
Unique R&D platform located in France
Customer-centric
Tailor-made approach to your needs
Strong emphasis on customer satisfaction
Collaborative partner
Long-standing partnerships with 17 of the top 20 pharma companies
Co-development of innovative models for next-generation drugs
Guaranteed FTO/freedom to operate